Implications of ABC transporters on the disposition of typical veterinary medicinal products
The ATP-Binding Cassette (ABC) transporters ABCB1, ABCC2 and ABCG2 are efflux transporters that facilitate the excretion of drugs, contribute to the function of biological barriers and maintain low cytoplasmic substrate concentrations in cells. ABC transporters modulate drug absorption, distribution and elimination according to the level of expression in the intestine, liver, kidney, and at biological barriers such as the blood-brain barrier. Moreover individual transporters are known to convey multi-drug resistance to tumour cells. While these diverse functions have been described in laboratory animal studies and in humans, the available information is very limited in animal species that are typical veterinary patients. This brief review summarizes the available data on organ distribution and expression levels in animals, genetic defects in dogs resulting in a non-functional P-gp expression, and describes examples of kinetic investigations directed to assess the clinical relevance of species differences in ABC-transporter expression.
Medienart: |
E-Artikel |
---|
Erscheinungsjahr: |
2008 |
---|---|
Erschienen: |
2008 |
Enthalten in: |
Zur Gesamtaufnahme - volume:585 |
---|---|
Enthalten in: |
European journal of pharmacology - 585(2008), 2-3 vom: 13. Mai, Seite 510-9 |
Sprache: |
Englisch |
---|
Beteiligte Personen: |
Schrickx, Jan A [VerfasserIn] |
---|
Links: |
---|
Themen: |
ABCC2 protein, human |
---|
Anmerkungen: |
Date Completed 18.07.2008 Date Revised 03.12.2021 published: Print-Electronic Citation Status MEDLINE |
---|
doi: |
10.1016/j.ejphar.2008.03.014 |
---|
funding: |
|
---|---|
Förderinstitution / Projekttitel: |
|
PPN (Katalog-ID): |
NLM178972827 |
---|
LEADER | 01000naa a22002652 4500 | ||
---|---|---|---|
001 | NLM178972827 | ||
003 | DE-627 | ||
005 | 20231223153007.0 | ||
007 | cr uuu---uuuuu | ||
008 | 231223s2008 xx |||||o 00| ||eng c | ||
024 | 7 | |a 10.1016/j.ejphar.2008.03.014 |2 doi | |
028 | 5 | 2 | |a pubmed24n0597.xml |
035 | |a (DE-627)NLM178972827 | ||
035 | |a (NLM)18417119 | ||
040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
041 | |a eng | ||
100 | 1 | |a Schrickx, Jan A |e verfasserin |4 aut | |
245 | 1 | 0 | |a Implications of ABC transporters on the disposition of typical veterinary medicinal products |
264 | 1 | |c 2008 | |
336 | |a Text |b txt |2 rdacontent | ||
337 | |a ƒaComputermedien |b c |2 rdamedia | ||
338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
500 | |a Date Completed 18.07.2008 | ||
500 | |a Date Revised 03.12.2021 | ||
500 | |a published: Print-Electronic | ||
500 | |a Citation Status MEDLINE | ||
520 | |a The ATP-Binding Cassette (ABC) transporters ABCB1, ABCC2 and ABCG2 are efflux transporters that facilitate the excretion of drugs, contribute to the function of biological barriers and maintain low cytoplasmic substrate concentrations in cells. ABC transporters modulate drug absorption, distribution and elimination according to the level of expression in the intestine, liver, kidney, and at biological barriers such as the blood-brain barrier. Moreover individual transporters are known to convey multi-drug resistance to tumour cells. While these diverse functions have been described in laboratory animal studies and in humans, the available information is very limited in animal species that are typical veterinary patients. This brief review summarizes the available data on organ distribution and expression levels in animals, genetic defects in dogs resulting in a non-functional P-gp expression, and describes examples of kinetic investigations directed to assess the clinical relevance of species differences in ABC-transporter expression | ||
650 | 4 | |a Journal Article | |
650 | 4 | |a Review | |
650 | 7 | |a ABCC2 protein, human |2 NLM | |
650 | 7 | |a ATP-Binding Cassette Transporters |2 NLM | |
650 | 7 | |a Multidrug Resistance-Associated Protein 2 |2 NLM | |
650 | 7 | |a Veterinary Drugs |2 NLM | |
700 | 1 | |a Fink-Gremmels, Johanna |e verfasserin |4 aut | |
773 | 0 | 8 | |i Enthalten in |t European journal of pharmacology |d 1967 |g 585(2008), 2-3 vom: 13. Mai, Seite 510-9 |w (DE-627)NLM000029769 |x 1879-0712 |7 nnns |
773 | 1 | 8 | |g volume:585 |g year:2008 |g number:2-3 |g day:13 |g month:05 |g pages:510-9 |
856 | 4 | 0 | |u http://dx.doi.org/10.1016/j.ejphar.2008.03.014 |3 Volltext |
912 | |a GBV_USEFLAG_A | ||
912 | |a GBV_NLM | ||
951 | |a AR | ||
952 | |d 585 |j 2008 |e 2-3 |b 13 |c 05 |h 510-9 |